Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Josefien P. van Olmen"'
Autor:
Josefien P. van Olmen, Veerle CM. Geurts, Marie-Jeanne TFD. Vrancken Peeters, Caroline A. Drukker, Marcel PM. Stokkel, Marleen Kok, Frederieke H. van Duijnhoven
Publikováno v:
Breast, Vol 78, Iss , Pp 103822- (2024)
Background: Guidelines recommend systemic therapy for stage I HER2+ breast cancer (BC). Neoadjuvant systemic treatment (NAST) allows response-guided adjuvant treatment. However, prior to NAST only clinical nodal staging is available, risking undertre
Externí odkaz:
https://doaj.org/article/c83b28677bb04a91a21da8b4b91658e4
Autor:
Josefien P. van Olmen, Chaja F. Jacobs, Sanne A.L. Bartels, Claudette E. Loo, Joyce Sanders, Marie-Jeanne T.F.D. Vrancken Peeters, Caroline A. Drukker, Frederieke H. van Duijnhoven, Marleen Kok
Publikováno v:
Breast, Vol 75, Iss , Pp 103726- (2024)
Objective: This study aims to evaluate the response to and surgical benefits of neoadjuvant endocrine therapy (NET) in ER+/HER2-breast cancer patients who are clinically high risk, but genomic low risk according to the 70-gene signature (MammaPrint).
Externí odkaz:
https://doaj.org/article/704ad2649c1245a2bc5b540ca828061f
Autor:
Annemiek K. E. van Hemert, Josefien P. van Olmen, Liesbeth J. Boersma, John H. Maduro, Nicola S. Russell, Jolien Tol, Ellen G. Engelhardt, Emiel J. Th. Rutgers, Marie-Jeanne T. F. D. Vrancken Peeters, Frederieke H. van Duijnhoven
Publikováno v:
Breast Cancer Research and Treatment, 199(1), 81-89. SPRINGER
Breast Cancer Research and Treatment, 199, 81-89. Springer, Cham
Breast Cancer Research and Treatment, 199, 81-89. Springer, Cham
Purpose: Neoadjuvant systemic therapy (NST) is increasingly used in breast cancer patients and depending on subtype, 10–89% of patients will attain pathologic complete response (pCR). In patients with pCR, risk of local recurrence (LR) after breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5759714b89fcb7a1feba2ec10948ea43
https://research.rug.nl/en/publications/c899ec1c-7e92-4b22-86c3-18ca97cce660
https://research.rug.nl/en/publications/c899ec1c-7e92-4b22-86c3-18ca97cce660
Autor:
Anne M. Schrama, Josefien P. van Olmen, Erienne M.V. de Cuba, R. Kwakman, Elisabeth A. te Velde, Geert Kazemier, René H. J. Otten, Elly S.M. de Lange-de Klerk
Publikováno v:
Kwakman, R, Schrama, A M, van Olmen, J P, Otten, R H, de lange-de Klerk, E S, de Cuba, E M, Kazemier, G & Velde, E A T 2016, ' Clinicopathological Parameters in Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Metastases A Meta-analysis ', Annals of Surgery, vol. 263, no. 6, pp. 1102-1111 . https://doi.org/10.1097/SLA.0000000000001593
Annals of Surgery, 263(6), 1102-1111. Lippincott Williams and Wilkins
Annals of Surgery, 263(6), 1102-1111. Lippincott Williams and Wilkins
To improve patient selection for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) by evaluating various preoperatively assessable clinicopathological parameters as markers for survival after CRS and HIPEC.Peritoneal m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02cc27ae427f8931f9436f9ee31ea158
https://research.vumc.nl/en/publications/1a12a9d9-f01a-4a8a-a673-f2906f2b9756
https://research.vumc.nl/en/publications/1a12a9d9-f01a-4a8a-a673-f2906f2b9756
